GSK snags Japanese approval for first hepatitis B functional cure, Hibsago
GSK has netted the first approval globally for its chronic hepatitis B therapy, bepirovirsen, from Japan’s Ministry of…
AstraZeneca shares slump after $400bn BMS merger rumours
Shares in AstraZeneca dropped by nearly 3% at market open after a report that the drugmaker is in…